Skip to content
PICO Portalanswers from OpenAlex

WAVE3 promotes proliferation, migration and invasion via the AKT pathway in pancreatic cancer

PaperCitations, authors & open-access status

WAVE3 promotes proliferation, migration and invasion via the AKT pathway in pancreatic cancer is a paper indexed in PICO Portal from OpenAlex.

How many citations does WAVE3 promotes proliferation, migration and invasion via the AKT pathway in pancreatic cancer have?

PICO Portalcitation count

WAVE3 promotes proliferation, migration and invasion via the AKT pathway in pancreatic cancer has 22 citations in the OpenAlex counts PICO Portal stores.

When was WAVE3 promotes proliferation, migration and invasion via the AKT pathway in pancreatic cancer published?

PICO Portalyear

WAVE3 promotes proliferation, migration and invasion via the AKT pathway in pancreatic cancer has 2018 year in the PICO Portal index.

What is the open-access status of WAVE3 promotes proliferation, migration and invasion via the AKT pathway in pancreatic cancer?

PICO Portaloa status

WAVE3 promotes proliferation, migration and invasion via the AKT pathway in pancreatic cancer has hybrid oa status in the PICO Portal index.

What is the DOI of WAVE3 promotes proliferation, migration and invasion via the AKT pathway in pancreatic cancer?

PICO Portaldoi

The DOI for WAVE3 promotes proliferation, migration and invasion via the AKT pathway in pancreatic cancer is on the source record.

What is the PMID of WAVE3 promotes proliferation, migration and invasion via the AKT pathway in pancreatic cancer?

PICO Portalpmid

The PMID for WAVE3 promotes proliferation, migration and invasion via the AKT pathway in pancreatic cancer is on the source record.

What is the OpenAlex record for WAVE3 promotes proliferation, migration and invasion via the AKT pathway in pancreatic cancer?

PICO Portalopenalex

The OpenAlex for WAVE3 promotes proliferation, migration and invasion via the AKT pathway in pancreatic cancer is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial